lidocaine (Compound)

Synonyms:lidocaine, 137-58-6, Lignocaine, Xylocaine, 2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide, Lidoderm, Alphacaine, Anestacon, Esracaine, Xylestesin, Duncaine, Cappicaine, Gravocain, Isicaina, L-Caine, Leostesin, Maricaine, Xylocain, Xylocitin, Solcain, Isicaine, Rucaina, Xilina, Xycaine, Xylotox, Cito optadren, Lida-Mantle, 2-(Diethylamino)-2',6'-acetoxylidide, Dentipatch, Dalcaine, Xyloneural (free base), Cuivasil, Jetocaine, Lidocainum, Remicaine, Xilocaina, 2-Diethylamino-N-(2,6-dimethylphenyl)acetamide, Acetamide, 2-(diethylamino)-N-(2,6-dimethylphenyl)-, Diethylaminoaceto-2,6-xylidide, ELA-Max, ZTlido, 2',6'-Acetoxylidide, 2-(diethylamino)-, alpha-Diethylamino-2,6-dimethylacetanilide, Lidocaton, alfa-Dietilamino-2,6-dimetilacetanilide, CHEBI:6456, Xylocaine (TN), CHEMBL79, NSC-40030, LIDOPEN, MLS000069724, ALGRX 3268, ALGRX-3268, Lignocainum, DTXSID1045166, Xllina, N-(2,6-dimethylphenyl)-N(2),N(2)-diethylglycinamide, Lidocaine (VAN), .alpha.-Diethylaminoaceto-2,6-xylidide, NCGC00015611-10, Xilocaina [Italian], Dilocaine, Lidocaina, SMR000058189, .alpha.-(Diethylamino)-2,6-acetoxylidide, Lidocaine Base, .alpha.-Diethylamino-2,6-dimethylacetanilide, .omega.-Diethylamino-2,6-dimethylacetanilide, 98PI200987, Lidocainum [INN-Latin], Lidocaina [INN-Spanish], N-(2,6-Dimethylphenyl)-N2,N2-diethylglycinamide, 2-(Diethylamino)-N-(2,6-Dimethylphenyl)ethanamide, EMBOLEX, DTXCID9025166, Versatis, Ztilido, 2-(Diethylamino)-N-(2,6-dimethylphenyl)-acetamide, Dentipatch (TN), 91484-71-8, CAS-137-58-6, LQZ, HSDB 3350, EINECS 205-302-8, MFCD00026733, NSC 40030, alfa-Dietilamino-2,6-dimetilacetanilide [Italian], BRN 2215784, Lidocain, Qualigens, Xyline, Lignocaine base, LidocaineHClH2O, Lidocaine [USP:INN:BAN:JAN], Lidocaine, powder, UNII-98PI200987, N1-(2,6-dimethylphenyl)-N2,N2-diethylglycinamide, Zingo (Salt/Mix), CDS1_000283, Lidocaine (Alphacaine), Spectrum_001118, Lidothesin (Salt/Mix), Xyloneural (Salt/Mix), LIDOCAINE [INN], LIDOCAINE [JAN], Opera_ID_385, LIDOCAINE [MI], LIDOCAINE [HSDB], LIDOCAINE [INCI], Maybridge1_002571, Prestwick0_000050, Prestwick1_000050, Prestwick2_000050, Prestwick3_000050, Spectrum2_001343, Spectrum3_001392, Spectrum4_000070, Spectrum5_001549, LIDOCAINE [VANDF], Lopac-L-5647, Lidaform HC (Salt/Mix), Epitope ID:116205, LIDOCAINE [MART.], Lidamantle HC (Salt/Mix), 2', 2-(diethylamino)-, LIDOCAINE [USP-RS], LIDOCAINE [WHO-DD], LIDOCAINE [WHO-IP], Neosporin Plus (Salt/Mix), Lopac0_000669, SCHEMBL15689, BSPBio_000179, BSPBio_001359, BSPBio_003004, KBioGR_000079, KBioGR_000599, KBioSS_000079, KBioSS_001598, 2-Diethylamino-N-(2,6-dimethyl-phenyl)-acetamide, 4-12-00-02538 (Beilstein Handbook Reference), MLS000758263, MLS001074177, MLS001423964, BIDD:GT0342, Diethylaminoacet-2,6-xylidide, DivK1c_000174, DivK1c_001323, Lidocaine, analytical standard, SPBio_001525, SPBio_002100, EMLA COMPONENT LIDOCAINE, Lidocaine (JP17/USP/INN), LIDOCAINE [GREEN BOOK], BPBio1_000197, GTPL2623, N-(2,6-dimethylphenyl)-N~2~,N~2~-diethylglycinamide, LIDOCAINE [ORANGE BOOK], LIDOCAINE [EP MONOGRAPH], SCHEMBL17967359, HMS548M19, KBio1_000174, KBio2_000079, KBio2_001598, KBio2_002647, KBio2_004166, KBio2_005215, KBio2_006734, KBio3_000157, KBio3_000158, KBio3_002224, ORAQIX COMPONENT LIDOCAINE, SYNERA COMPONENT LIDOCAINE, LIDOCAINE [USP MONOGRAPH], Lidocaine 1.0 mg/ml in Methanol, LIDOCAINUM [WHO-IP LATIN], NINDS_000174, Bio1_000379, Bio1_000868, Bio1_001357, Bio2_000079, Bio2_000559, HMS1791D21, HMS1989D21, HMS2051C21, HMS2089E15, HMS2235O14, HMS3371J04, HMS3393C21, HMS3428O07, HMS3651G09, LIDOCAINE COMPONENT OF EMLA, FORTACIN COMPONENT LIDOCAINE, AMY25560, BCP09081, HY-B0185, NSC40030, LIDOCAINE COMPONENT OF ORAQIX, LIDOCAINE COMPONENT OF SYNERA, Tox21_110183, 2-diethylamino-2',6'-acetoxylidide, BDBM50017662, LANABIOTIC COMPONENT LIDOCAINE, NSC789222, s1357, STK552033, AKOS001026768, LIDOCAIN COMPONENT OF FORTACINE, Tox21_110183_1, CCG-100824, CS-2070, DB00281, NC00074, NSC-789222, ROCEPHIN KIT COMPONENT LIDOCAINE, SB19118, SDCCGSBI-0050648.P005, WLN: 2N2 & 1VMR B1 F1, .alpha.-Diethylamino-2,6-acetoxylidide, CAS-73-78-9, IDI1_000174, IDI1_033829, LIDOCAINE COMPONENT OF LANABIOTIC, NCGC00015611-01, NCGC00015611-02, NCGC00015611-03, NCGC00015611-04, NCGC00015611-05, NCGC00015611-06, NCGC00015611-07, NCGC00015611-08, NCGC00015611-09, NCGC00015611-11, NCGC00015611-12, NCGC00015611-13, NCGC00015611-14, NCGC00015611-15, NCGC00015611-16, NCGC00015611-18, NCGC00015611-31, NCGC00022176-05, NCGC00022176-06, NCGC00022176-07, NCGC00022176-08, NCGC00022176-09, AC-10282, AS-13718, SY052029, 2-(Diethylamino)-2'',6''-acetoxylidide, LIDOCAINE COMPONENT OF ROCEPHIN KIT, SBI-0050648.P004, DIETHYLAMINO-2,6-DIMETHYLACETANILIDE, AB00053581, L0156, SW196598-4, A18187, C07073, D00358, M06299, AB00053581-27, AB00053581-28, AB00053581_29, AB00053581_30, EN300-6472705, A833036, Q216935, (2,6-dimethylphenyl)carbamoylmethyl-diethyl-azanium, N1-(2,6-dimethylphenyl)-2-(diethylamino)acetamide, W-108233, 2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide #, BRD-K52662033-001-02-6, BRD-K52662033-003-05-5, BRD-K52662033-003-14-7, Z55135799, Lidocaine, British Pharmacopoeia (BP) Reference Standard, Lidocaine, European Pharmacopoeia (EP) Reference Standard, N~1~-(2,6-dimethylphenyl)-N~2~,N~2~-diethylglycinamide, Lidocaine, United States Pharmacopeia (USP) Reference Standard, 2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide hydrate hydrochloride, Lidocaine, Pharmaceutical Secondary Standard; Certified Reference Material

Pubchem:PUBCHEM:3676

Id:8a179817-19cc-5109-9dc5-337aec5c389d

Description:nan